You are here

Merck

Merck bets $700M on an antibody drug’s potential in immune diseases

BioPharma Dive

Fri, 08/9/24 - 11:57 am

autoimmune disease

Curon Biopharmaceutical

bispecific antibodies

Pharma execs react to final drug price negotiations with Medicare

Pharma Voice

Fri, 08/9/24 - 11:21 am

Inflation Reduction Act

Bristol Myers Squibb

Gardasil Chinese Distribution Issue Still a Mystery to Analysts

BioSpace

Thu, 08/8/24 - 11:12 am

Market share shakeup: Big Pharma’s bestselling drugs drive industry shifts in 2024’s first half

Pharma Voice

Thu, 08/8/24 - 11:07 am

Merck stops phase 3 TIGIT trial in lung cancer for futility—and sees immune side effects again

Fierce Biotech

Thu, 08/8/24 - 11:04 am

clinical trials

Merck advances lung cancer attack, pocketing $170M from Daiichi and plotting ADC-trispecific combo

Fierce Biotech

Tue, 08/6/24 - 11:20 am

Harpoon Therapeutics

small cell lung cancer

3 Big Pharma companies, 33 phase 3 trials: The race for supremacy in an ADC field

Fierce Pharma

Mon, 08/5/24 - 11:41 am

Gilead Sciences

clinical trials

antibody-drug conjugates

Daiichi Sankyo and MSD announce first subject dosing in lung cancer trial

Clinical Trials Arena

Fri, 08/2/24 - 11:50 am

clinical trials

small cell lung cancer

GSK blows Jemperli marching brass against Keytruda with expanded FDA nod in endometrial cancer

Fierce Pharma

Thu, 08/1/24 - 11:19 pm

endometrial cancer

Merck mystified by sudden 'step down' in Gardasil sales in China

Fierce Pharma

Tue, 07/30/24 - 06:36 pm

Merck (MRK) Q2 Earnings and Revenues Top Estimates

Yahoo/Zacks.com

Tue, 07/30/24 - 06:33 pm

BioNTech, Regeneron’s mRNA Cancer Vaccine Combo Clears Phase II in Melanoma

BioSpace

Tue, 07/30/24 - 11:41 am

Moderna Therapeutics

Should Merck Buy Out Moderna on Keytruda–Cancer Vaccine Partnership?

BioSpace

Wed, 07/24/24 - 11:02 pm

Moderna Therapeutics

cancer vaccines

Merck, Rapt, Aslan and more cut staff

Pharma Live

Wed, 07/24/24 - 11:58 am

RAPT Therapeutics

Caribou Biosciences

Spark Therapeutics

Merck claims late-stage study success for RSV antibody

BioPharma Dive

Tue, 07/23/24 - 11:36 am

Merck launches GMP-compliant cell culture media line in China

Pharmaceutical Business Review

Wed, 07/17/24 - 12:13 pm

drug manufacturing

cell culture media

Novo Nordisk's Ozempic cuts dementia risk compared with Merck's Januvia: Oxford study

Fierce Pharma

Fri, 07/12/24 - 11:28 am

Merck puts 1,000-plus Zostavax lawsuits to bed after plaintiffs file for dismissal

Fierce Pharma

Tue, 07/9/24 - 11:23 am

Merck opts in on Orion's hormone-dependent cancer candidates

Fierce Biotech

Mon, 07/1/24 - 09:51 pm

Merck's Capvaxive gears up to challenge Pfizer's dominant Prevnar with CDC panel backing

Fierce Pharma

Sun, 06/30/24 - 09:59 pm

pneumococcal disease

Pages